AMA Wants To Stop Pharma Pay-To-Delay Tactic On Generics

News | 13 November 2012

• Print This

The American Medical Association is urging Congress and federal regulators to end the drug industry practice of "pay for delay" which allows brand name pharmaceutical companies to pay generic drug makers to keep cheaper prescriptions off the market.

Click on the link to read the full article at Forbes
(This link will open in a new window)